Editorial
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2011; 17(39): 4349-4364
Published online Oct 21, 2011. doi: 10.3748/wjg.v17.i39.4349
Table 3 Epidemiological and clinical characteristics of patients in the 18 retrospective studies involving patients with a benign cystic duodenal wall (continues from Table 2) n (%)
Author[Ref.] yrImagingDuodenal findingsCBD stenosisDuodenal stenosis
Stolte et al[7] 1982NRBrunner hyperplasia in 2515 (50.0)NR
Yamaguchi et al[10] 1992US, CT, ERCP, PTCEdema and nodular appearance; Brunner hyperplasia4 (50.0)5 (62.5)
Fléjou et al[11] 1993ERCP, EUSEdema and congestion of the mucosa07 (70.0)
Itoh et al[12] 1994CTNRNRNR
Fékété et al[13] 1996CT, ERCP, EUSEdema and congestion of the mucosa05 (83.3)
Procacci et al[16] 1997CT, ERCP, EUSInflammation in 82 (20.0)2 (20.0)
Irie et al[18] 1998MRIBrunner hyperplasia in 32 (40.0)3 (60.0)
Vullierme et al[23] 2000CTNR3 (15.0)20 (100)
Aoun et al[81] 2005US, CT, ERCP, EUSNR4 (100)NR
Pessaux et al[36] 2006US, EUS, CT, ERCP, MRINRNRNR
Jouannaud et al[37] 2006EUS, CTInflammation in 3NR8 (34.8)
Tison et al[39] 2007US, CT, MRI, angiographyNon specific inflammation in 95 (55.6)9 (100)
Rebours et al[40] 2007CT, EUSBrunner hyperplasia in 6126 (24.8)50 (47.6)
Rahman et al[46] 2007CT, MRI, EUSBrunner hyperplasia05 (45.5)
Castell-Monsalve et al[47] 2008MRI, EUSDuodenal stenosis in 33 (60.0)3 (60.0)
Jovanovic et al[52] 2008US, CT, MRI, EUSNR6 (46.2)NR
Casetti et al[63] 2009US, CT, MRI, EUSNR3 (5.2)NR
Ishigami et al[6] 2010CT, MRINR9 (60.0)NR
Overall--82/309117/212
(26.50)(55.20)